Connect with a specialist: [ Ссылка ]
Meet Jerry Mendell, MD: [ Ссылка ]
More about SMA Type 1: [ Ссылка ]
More on Research: [ Ссылка ]
A one-time intravenous infusion of the high dose of gene therapy extended the survival of patients with spinal muscular atrophy type 1 (SMA1) in a Phase 1 clinical trial, according to a study published Nov. 1, 2017 in the New England Journal of Medicine. This animation describes how the process works.
